EC-NAPROSYN vs XIFYRM

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 20, 2026·How we rate

Possible drug interaction. EC-NAPROSYN and XIFYRM are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EC-NAPROSYN	XIFYRM
Rating	New	70/100
Pharmacy pays	$0.06 /mL	~$0.56 /30
Type	RX	RX
Active ingredient	NAPROXEN	MELOXICAM
Manufacturer	Atnahs Pharma US	Azurity
Dosage forms	Tablet, delayed release	Injectable
Drug class	Nonsteroidal Anti-Inflammatory Drug	Nonsteroidal Anti-Inflammatory Drug
Boxed warning	Boxed warning	Boxed warning
Half-life	about 12 to 17 hours	about 15 to 20 hours
Treats	Juvenile Arthritis, Rheumatoid Arthritis, Back Pain	Rheumatoid Arthritis, Osteoarthritis

ec-naprosyn xifyrm

Rating

New

70/100

Pharmacy pays

$0.06 /mL

~$0.56 /30

Type

Active ingredient

NAPROXEN

MELOXICAM

Manufacturer

Atnahs Pharma US

Azurity

Dosage forms

Tablet, delayed release

Injectable

Drug class

Nonsteroidal Anti-Inflammatory Drug

Boxed warning

Half-life

about 12 to 17 hours

about 15 to 20 hours

Treats

Juvenile Arthritis, Rheumatoid Arthritis, Back Pain

Rheumatoid Arthritis, Osteoarthritis

Frequently asked questions

What is the difference between Ec-Naprosyn and Xifyrm?

Ec-Naprosyn contains Naproxen, while Xifyrm contains Meloxicam — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.